Jared Barsky

Array ( [id] => 12009867 [patent_doc_number] => 09803174 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-31 [patent_title] => 'Neural progenitor cell populations' [patent_app_type] => utility [patent_app_number] => 13/558078 [patent_app_country] => US [patent_app_date] => 2012-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16129 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13558078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8670696 [patent_doc_number] => 20130045234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-21 [patent_title] => 'NEUTRALIZING FACTORS AS VACCINE ADJUVANTS' [patent_app_type] => utility [patent_app_number] => 13/549883 [patent_app_country] => US [patent_app_date] => 2012-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10230 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13549883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8618341 [patent_doc_number] => 20130023653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'Tissue Specific Expression Of Antibodies In Chickens' [patent_app_type] => utility [patent_app_number] => 13/550488 [patent_app_country] => US [patent_app_date] => 2012-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15981 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13550488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8467176 [patent_doc_number] => 20120272344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'TRANSGENIC ANIMALS EXPRESSING CHIMERIC ANTIBODIES FOR USE IN PREPARING HUMAN ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/540386 [patent_app_country] => US [patent_app_date] => 2012-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16422 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13540386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8891142 [patent_doc_number] => 20130164326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'CHIMERIC ADENOVIRAL VECTORS' [patent_app_type] => utility [patent_app_number] => 13/532701 [patent_app_country] => US [patent_app_date] => 2012-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15728 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13532701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8779651 [patent_doc_number] => 20130101625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'MODIFIED CEA NUCLEIC ACID AND EXPRESSION VECTORS' [patent_app_type] => utility [patent_app_number] => 13/532035 [patent_app_country] => US [patent_app_date] => 2012-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13601 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13532035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9572183 [patent_doc_number] => 20140189897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-03 [patent_title] => 'TRANSGENIC ANIMALS CAPABLE OF BEING INDUCED TO DELETE SENESCENT CELLS' [patent_app_type] => utility [patent_app_number] => 14/125841 [patent_app_country] => US [patent_app_date] => 2012-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 8231 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8670955 [patent_doc_number] => 20130045492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-21 [patent_title] => 'Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain' [patent_app_type] => utility [patent_app_number] => 13/488628 [patent_app_country] => US [patent_app_date] => 2012-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 41343 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13488628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8832045 [patent_doc_number] => 20130133090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'TRANSGENIC MAMMALLS MODIFIED IN BRI PROTEIN EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/477397 [patent_app_country] => US [patent_app_date] => 2012-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 12821 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13477397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8489065 [patent_doc_number] => 20120288472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'REGULATION OF T CELL-MEDIATED IMMUNITY BY TRYPTOPHAN' [patent_app_type] => utility [patent_app_number] => 13/476183 [patent_app_country] => US [patent_app_date] => 2012-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15184 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13476183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8994817 [patent_doc_number] => 08518701 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Methods and materials for producing transgenic artiodactyls' [patent_app_type] => utility [patent_app_number] => 13/467588 [patent_app_country] => US [patent_app_date] => 2012-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 11 [patent_no_of_words] => 16961 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13467588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8453166 [patent_doc_number] => 20120264112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY' [patent_app_type] => utility [patent_app_number] => 13/456330 [patent_app_country] => US [patent_app_date] => 2012-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4544 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13456330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9517733 [patent_doc_number] => 20140154225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-05 [patent_title] => 'METHOD FOR COMBINED CONDITIONING AND CHEMOSELECTION IN A SINGLE CYCLE' [patent_app_type] => utility [patent_app_number] => 14/112878 [patent_app_country] => US [patent_app_date] => 2012-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11465 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8495936 [patent_doc_number] => 20120295344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'Stem Cell Fusion Model of Carcinogenesis' [patent_app_type] => utility [patent_app_number] => 13/448251 [patent_app_country] => US [patent_app_date] => 2012-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12803 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13448251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335101 [patent_doc_number] => 20120201808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'Stem Cell Fusion Model of Carcinogenesis' [patent_app_type] => utility [patent_app_number] => 13/448112 [patent_app_country] => US [patent_app_date] => 2012-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6827 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13448112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8699329 [patent_doc_number] => 20130061338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'SCREENING OF DRUG FOR ATTENTION DEFICIT HYPERACTIVE DISORDER BY USING GIT1 KNOCK-OUT MICE AS A NOVEL ADHD MOUSE MODEL' [patent_app_type] => utility [patent_app_number] => 13/446789 [patent_app_country] => US [patent_app_date] => 2012-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5568 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13446789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9437819 [patent_doc_number] => 20140115726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-24 [patent_title] => 'NEW TALE-PROTEIN SCAFFOLDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/009509 [patent_app_country] => US [patent_app_date] => 2012-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 35113 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14009509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8315290 [patent_doc_number] => 20120192300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'Common Light Chain Mouse' [patent_app_type] => utility [patent_app_number] => 13/412936 [patent_app_country] => US [patent_app_date] => 2012-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 34453 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13412936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8670642 [patent_doc_number] => 20130045180 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2013-02-21 [patent_title] => 'VACCINES, IMMUNOTHERAPEUTICS AND METHODS FOR USING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/360389 [patent_app_country] => US [patent_app_date] => 2012-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 30629 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13360389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8670642 [patent_doc_number] => 20130045180 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2013-02-21 [patent_title] => 'VACCINES, IMMUNOTHERAPEUTICS AND METHODS FOR USING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/360389 [patent_app_country] => US [patent_app_date] => 2012-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 30629 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13360389 [rel_patent_id] =>[rel_patent_doc_number] =>)